Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000215457-16-002510
Filing Date
2016-01-26
Accepted
2016-01-26 08:19:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 dynavax.technologi.2015.txt SC 13G/A 11442
  Complete submission text file 0000215457-16-002510.txt   13187
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Subject) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80035 | Film No.: 161360191
SIC: 2834 Pharmaceutical Preparations

Mailing Address 55 EAST 52ND STREET NEW YORK NY 10055
Business Address 55 EAST 52ND STREET NEW YORK NY 10055 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

EIN.: 320174431 | State of Incorp.: DE | Fiscal Year End: 0226
Type: SC 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies